The store will not work correctly when cookies are disabled.
1-(cyclopropylmethyl)-5-phenyl-4,5,6,7-tetrahydro-1H-[1,2,3]triazolo[4,5-c]pyridine
ID: ALA4293372
PubChem CID: 145989437
Max Phase: Preclinical
Molecular Formula: C15H18N4
Molecular Weight: 254.34
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: c1ccc(N2CCc3c(nnn3CC3CC3)C2)cc1
Standard InChI: InChI=1S/C15H18N4/c1-2-4-13(5-3-1)18-9-8-15-14(11-18)16-17-19(15)10-12-6-7-12/h1-5,12H,6-11H2
Standard InChI Key: YODWJQMJBYJEDL-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 22 0 0 0 0 0 0 0 0999 V2000
37.8257 -2.6453 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.6572 -1.8476 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.0491 -2.3911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3732 -3.2506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.1191 -4.0248 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.6012 -4.6891 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.1191 -5.3533 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.3370 -5.1008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6311 -5.5176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9210 -5.1008 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.9210 -4.2791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6311 -3.8740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.3370 -4.2776 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2156 -5.5054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5060 -5.0930 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8006 -5.4976 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8006 -6.3126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5000 -6.7290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2156 -6.3264 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
1 3 1 0
1 4 1 0
4 5 1 0
5 6 1 0
6 7 2 0
7 8 1 0
9 8 1 0
10 9 1 0
10 11 1 0
12 11 1 0
13 12 1 0
8 13 2 0
5 13 1 0
14 10 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
14 19 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 254.34 | Molecular Weight (Monoisotopic): 254.1531 | AlogP: 2.25 | #Rotatable Bonds: 3 |
Polar Surface Area: 33.95 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 0.83 | CX LogP: 2.45 | CX LogD: 2.45 |
Aromatic Rings: 2 | Heavy Atoms: 19 | QED Weighted: 0.84 | Np Likeness Score: -1.70 |
References
1. Karypidou K, Ribone SR, Quevedo MA, Persoons L, Pannecouque C, Helsen C, Claessens F, Dehaen W.. (2018) Synthesis, biological evaluation and molecular modeling of a novel series of fused 1,2,3-triazoles as potential anti-coronavirus agents., 28 (21): [PMID:30286952] [10.1016/j.bmcl.2018.09.019] |